Table 2: The cell markers and inhibitors in clinical trials.

MarkerInhibitors in clinical trials

IGF 1 and 2
IGF-1 receptor
IMC-A12 (Cixutumumab)
OSI-906

Vascular endothelial growth factor (VEGF)Sorafenib
Axitinib
Bevacizumab

mTOR (mammalian target of rapamycin)Temsirolimus